Inj., kanjinti, 10 mg
Full descriptor
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
Details
- Code
- Q5117
- Short descriptor
- Inj., kanjinti, 10 mg
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Oct 1 2019
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Inj., trazimera, 10 mg
Inj., zirabev, 10 mg
Inj ruxience, 10 mg
Inj truxima 10 mg
Inj pegfilgrastim-bmez 0.5mg
Inj ogivri 10 mg
Inj. avsola, 10 mg
Inj herzuma 10 mg
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.